Patients with end stage renal disease show reduced ability to respond against both new and recall antigens

Abstract

Patients with End Stage Renal Disease (ESRD) show immunosenescence secondary to the renal dysfunction. To analyse the relationship between this process and the ability to respond to new or recall antigens we studied the cellular memory generated against both the SARS-CoV-2 new vaccine, and the seasonal Influenza vaccine (InV).